Reata Pharmaceuticals Inc. (RETA)

181.97
NASDAQ : Health Technology
Prev Close 184.91
Day Low/High 176.22 / 189.39
52 Wk Low/High 47.50 / 185.53
Avg Volume 382.50K
Exchange NASDAQ
Shares Outstanding 24.48M
Market Cap 5.57B
EPS -2.90
P/E Ratio N/A
Div & Yield N.A. (N.A)
Commit To Buy Reata Pharmaceuticals At $25, Earn 20% Using Options

Commit To Buy Reata Pharmaceuticals At $25, Earn 20% Using Options

Investors eyeing a purchase of Reata Pharmaceuticals Inc stock, but tentative about paying the going market price of $28.24/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2019 put at the $25 strike, which has a bid at the time of this writing of $5.00.

Here Comes a Big Breakout For Alibaba

Here Comes a Big Breakout For Alibaba

What the charts say.

Reata Pharmaceuticals Enters Oversold Territory (RETA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Reata Pharmaceuticals Stock Initiated With 'Buy' Rating

Reata Pharmaceuticals Stock Initiated With 'Buy' Rating

Reata Pharmaceuticals had coverage initiated with a 'buy' rating.

5 Stocks Insiders Love Right Now

5 Stocks Insiders Love Right Now

Insiders at these companies -- including Wynn Resorts and Virtu Financial -- have been scooping up shares of their own stock lately.

TheStreet Quant Rating: D (Sell)